MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on August 14, 2025, by MDxHealth SA, a foreign private issuer based in Herstal, Belgium, serves to report the Company's 2025 Interim Report. The filing incorporates the interim report as Exhibit 99.1 and confirms the accuracy of preliminary financial results previously disclosed in a press release dated August 5, 2025.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing acts as a cover document referencing the detailed financial data contained in the attached 2025 Interim Report (Exhibit 99.1) and the August 5, 2025 press release.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance compared to prior periods. It only confirms the accuracy of preliminary results filed earlier in the month.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the cover text of this Form 6-K. The document notes that it is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its liability scope unless expressly incorporated by reference.
Investor Verification Checklist
- Review the attached 2025 Interim Report (Exhibit 99.1) for detailed financial statements.
- Verify the preliminary financial results disclosed in the press release filed on August 5, 2025.
- Confirm the incorporation of this report into the Company's Registration Statements on Form F-3 (File Nos. 333-268885 and 333-280606).
- Note that the filing is signed by Michael McGarrity, Chief Executive Officer, on August 14, 2025.